Lipocalin 2 is protective against E. coli pneumonia

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Lipocalin 2 is protective against E. coli pneumonia. / Wu, Hong; Santoni-Rugiu, Eric; Ralfkiaer, Elisabeth; Porse, Bo T; Moser, Claus; Høiby, Niels; Borregaard, Niels; Cowland, Jack B; Wu, Hong; Santoni-Rugiu, Eric; Ralfkiær, Elisabeth; Porse, Bo Torben; Moser, Claus Ernst; Høiby, Niels; Borregaard, Niels; Cowland, Jack.

In: Respiratory research (Online), Vol. 11, No. 96, 15.06.2010.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Wu, H, Santoni-Rugiu, E, Ralfkiaer, E, Porse, BT, Moser, C, Høiby, N, Borregaard, N, Cowland, JB, Wu, H, Santoni-Rugiu, E, Ralfkiær, E, Porse, BT, Moser, CE, Høiby, N, Borregaard, N & Cowland, J 2010, 'Lipocalin 2 is protective against E. coli pneumonia', Respiratory research (Online), vol. 11, no. 96. https://doi.org/10.1186/1465-9921-11-96, https://doi.org/10.1186/1465-9921-11-96

APA

Wu, H., Santoni-Rugiu, E., Ralfkiaer, E., Porse, B. T., Moser, C., Høiby, N., Borregaard, N., Cowland, J. B., Wu, H., Santoni-Rugiu, E., Ralfkiær, E., Porse, B. T., Moser, C. E., Høiby, N., Borregaard, N., & Cowland, J. (2010). Lipocalin 2 is protective against E. coli pneumonia. Respiratory research (Online), 11(96). https://doi.org/10.1186/1465-9921-11-96, https://doi.org/10.1186/1465-9921-11-96

Vancouver

Wu H, Santoni-Rugiu E, Ralfkiaer E, Porse BT, Moser C, Høiby N et al. Lipocalin 2 is protective against E. coli pneumonia. Respiratory research (Online). 2010 Jun 15;11(96). https://doi.org/10.1186/1465-9921-11-96, https://doi.org/10.1186/1465-9921-11-96

Author

Wu, Hong ; Santoni-Rugiu, Eric ; Ralfkiaer, Elisabeth ; Porse, Bo T ; Moser, Claus ; Høiby, Niels ; Borregaard, Niels ; Cowland, Jack B ; Wu, Hong ; Santoni-Rugiu, Eric ; Ralfkiær, Elisabeth ; Porse, Bo Torben ; Moser, Claus Ernst ; Høiby, Niels ; Borregaard, Niels ; Cowland, Jack. / Lipocalin 2 is protective against E. coli pneumonia. In: Respiratory research (Online). 2010 ; Vol. 11, No. 96.

Bibtex

@article{756f42e0b43011df825b000ea68e967b,
title = "Lipocalin 2 is protective against E. coli pneumonia",
abstract = "BACKGROUND: Lipocalin 2 is a bacteriostatic protein that binds the siderophore enterobactin, an iron-chelating molecule produced by Escherichia coli (E. coli) that is required for bacterial growth. Infection of the lungs by E. coli is rare despite a frequent exposure to this commensal bacterium. Lipocalin 2 is an effector molecule of the innate immune system and could therefore play a role in hindering growth of E. coli in the lungs. METHODS: Lipocalin 2 knock-out and wild type mice were infected with two strains of E. coli. The lungs were removed 48 hours post-infection and examined for lipocalin 2 and MMP9 (a myeloid marker protein) by immunohistochemical staining and western blotting. Bacterial numbers were assessed in the lungs of the mice at 2 and 5 days after infection and mortality of the mice was monitored over a five-day period. The effect of administering ferrichrome (an iron source that cannot be bound by lipocalin 2) along with E.coli was also examined. RESULTS: Intratracheal installation of E. coli in mice resulted in strong induction of lipocalin 2 expression in bronchial epithelium and alveolar type II pneumocytes. Migration of myeloid cells to the site of infection also contributed to an increased lipocalin 2 level in the lungs. Significant higher bacterial numbers were observed in the lungs of lipocalin 2 knock-out mice on days 2 and 5 after infection with E. coli (p < 0.05). In addition, a higher number of E. coli was found in the spleen of surviving lipocalin 2 knock-out mice on day 5 post-infection than in the corresponding wild-type mice (p < 0.05). The protective effect against E. coli infection in wild type mice could be counteracted by the siderophore ferrichrome, indicating that the protective effect of lipocalin 2 depends on its ability to sequester iron. CONCLUSIONS: Lipocalin 2 is important for protection of airways against infection by E. coli.",
author = "Hong Wu and Eric Santoni-Rugiu and Elisabeth Ralfkiaer and Porse, {Bo T} and Claus Moser and Niels H{\o}iby and Niels Borregaard and Cowland, {Jack B} and Hong Wu and Eric Santoni-Rugiu and Elisabeth Ralfki{\ae}r and Porse, {Bo Torben} and Moser, {Claus Ernst} and Niels H{\o}iby and Niels Borregaard and Jack Cowland",
year = "2010",
month = jun,
day = "15",
doi = "10.1186/1465-9921-11-96",
language = "English",
volume = "11",
journal = "Respiratory Research (Print)",
issn = "1465-9921",
publisher = "BioMed Central Ltd.",
number = "96",

}

RIS

TY - JOUR

T1 - Lipocalin 2 is protective against E. coli pneumonia

AU - Wu, Hong

AU - Santoni-Rugiu, Eric

AU - Ralfkiaer, Elisabeth

AU - Porse, Bo T

AU - Moser, Claus

AU - Høiby, Niels

AU - Borregaard, Niels

AU - Cowland, Jack B

AU - Wu, Hong

AU - Santoni-Rugiu, Eric

AU - Ralfkiær, Elisabeth

AU - Porse, Bo Torben

AU - Moser, Claus Ernst

AU - Høiby, Niels

AU - Borregaard, Niels

AU - Cowland, Jack

PY - 2010/6/15

Y1 - 2010/6/15

N2 - BACKGROUND: Lipocalin 2 is a bacteriostatic protein that binds the siderophore enterobactin, an iron-chelating molecule produced by Escherichia coli (E. coli) that is required for bacterial growth. Infection of the lungs by E. coli is rare despite a frequent exposure to this commensal bacterium. Lipocalin 2 is an effector molecule of the innate immune system and could therefore play a role in hindering growth of E. coli in the lungs. METHODS: Lipocalin 2 knock-out and wild type mice were infected with two strains of E. coli. The lungs were removed 48 hours post-infection and examined for lipocalin 2 and MMP9 (a myeloid marker protein) by immunohistochemical staining and western blotting. Bacterial numbers were assessed in the lungs of the mice at 2 and 5 days after infection and mortality of the mice was monitored over a five-day period. The effect of administering ferrichrome (an iron source that cannot be bound by lipocalin 2) along with E.coli was also examined. RESULTS: Intratracheal installation of E. coli in mice resulted in strong induction of lipocalin 2 expression in bronchial epithelium and alveolar type II pneumocytes. Migration of myeloid cells to the site of infection also contributed to an increased lipocalin 2 level in the lungs. Significant higher bacterial numbers were observed in the lungs of lipocalin 2 knock-out mice on days 2 and 5 after infection with E. coli (p < 0.05). In addition, a higher number of E. coli was found in the spleen of surviving lipocalin 2 knock-out mice on day 5 post-infection than in the corresponding wild-type mice (p < 0.05). The protective effect against E. coli infection in wild type mice could be counteracted by the siderophore ferrichrome, indicating that the protective effect of lipocalin 2 depends on its ability to sequester iron. CONCLUSIONS: Lipocalin 2 is important for protection of airways against infection by E. coli.

AB - BACKGROUND: Lipocalin 2 is a bacteriostatic protein that binds the siderophore enterobactin, an iron-chelating molecule produced by Escherichia coli (E. coli) that is required for bacterial growth. Infection of the lungs by E. coli is rare despite a frequent exposure to this commensal bacterium. Lipocalin 2 is an effector molecule of the innate immune system and could therefore play a role in hindering growth of E. coli in the lungs. METHODS: Lipocalin 2 knock-out and wild type mice were infected with two strains of E. coli. The lungs were removed 48 hours post-infection and examined for lipocalin 2 and MMP9 (a myeloid marker protein) by immunohistochemical staining and western blotting. Bacterial numbers were assessed in the lungs of the mice at 2 and 5 days after infection and mortality of the mice was monitored over a five-day period. The effect of administering ferrichrome (an iron source that cannot be bound by lipocalin 2) along with E.coli was also examined. RESULTS: Intratracheal installation of E. coli in mice resulted in strong induction of lipocalin 2 expression in bronchial epithelium and alveolar type II pneumocytes. Migration of myeloid cells to the site of infection also contributed to an increased lipocalin 2 level in the lungs. Significant higher bacterial numbers were observed in the lungs of lipocalin 2 knock-out mice on days 2 and 5 after infection with E. coli (p < 0.05). In addition, a higher number of E. coli was found in the spleen of surviving lipocalin 2 knock-out mice on day 5 post-infection than in the corresponding wild-type mice (p < 0.05). The protective effect against E. coli infection in wild type mice could be counteracted by the siderophore ferrichrome, indicating that the protective effect of lipocalin 2 depends on its ability to sequester iron. CONCLUSIONS: Lipocalin 2 is important for protection of airways against infection by E. coli.

U2 - 10.1186/1465-9921-11-96

DO - 10.1186/1465-9921-11-96

M3 - Journal article

C2 - 20633248

VL - 11

JO - Respiratory Research (Print)

JF - Respiratory Research (Print)

SN - 1465-9921

IS - 96

ER -

ID: 21661619